Follicular dendritic cells

Follicular dendritic cells (FDCs) are cells of the immune system found in primary and secondary lymph follicles of the B cell areas of the lymphoid tissue.[1][2][3] Unlike DCs, FDCs are not derived from the bone-marrow hematopoietic stem cell, but are of mesenchymal origin.[4]

Location and molecular markersEdit

Follicular DCs are a non-migratory population found in primary and secondary follicles of the B cell areas of lymph nodes, spleen, and mucosa-associated lymphoid tissue (MALT). They form a stable network due to intercellular connections between FDCs processes and intimate interaction with follicular B cells.[5][6] Follicular DCs network typically forms the center of the follicle and does not extend from the follicle to the interfollicular regions or T- cell zone. Supposedly, this separation from the sites of earliest antigen processing and capture provide a protected environment in which opsonized antigens can be displayed for a long time without being proteolyzed or removed by phagocytic cells. Follicular DCs have high expression of complement receptors CR1 and CR2 (CD 35 and CD 21 respectively) and Fc-receptor FcγRIIb (CD32). Further FDCs specific molecular markers are FDC-M1, FDC-M2 and C4.[7] Unlike other DCs and macrophages, FDCs lack MHC class II antigen molecules and express few pattern-recognition receptors, so they have little ability to capture non-opsonized antigens.[5]


Follicular DCs develop from putative mesenchymal precursors.[7] Severe combined immunodeficiency (SCID) mice models demonstrate that these precursors may be transmitted to recipients with bone marrow allotransplants, in which case both donors' and recipients' FDCs networks may later be found in recipients' lymphoid compartments.[8] Interaction between FDCs precursors and lymphoid cells mediated by TNF-a and lymphotoxin (LT) is crucial for normal FDC development and maintenance. TNF-a binds on the TNFRI receptor, while LT interacts with LTβ-receptor expressed on FDC precursors. In mice lacking B cells, or with blocked TNF-a and lymphotoxin (LT) production, cells with FDC phenotype are missing.[9][10]


Organizing lymphoid microarchitectureEdit

In normal lymphoid tissue recirculating resting B cells migrate through the FDC networks, whereas antigen-activated B cells are intercepted and undergo clonal expansion within the FDC networks, generating germinal centers (GC). FDCs are among main producers of the chemokine CXCL13 which attracts and organises lymphoid cells.[11]

Antigen capturing, memory B-cell supportEdit

Follicular DCs receptors CR1, CR2 and FcγRIIb trap antigen opsonized by complement or antibodies. These antigens are then taken up in a non-degradative cycling endosomal compartment for later presentation to B cells.[12] To become selected as a future memory cell, GC B cells must bind the antigen presented on FDCs, otherwise they enter apoptosis.

Debris removalEdit

By secreting the bridging factor MFGE8, which crosslinks apoptotic cells and phagocytes, FDCs promote selective debris removal from the GC.[13][14]

Preventing autoimmunityEdit

Factor Mfge produced in lymphoid tissues mainly by FDCs is known to enhance engulfment of apoptotic cells. Deficit of this factor in mice leads to a state resembling systemic lupus erythematosus (SLE). Furthermore, mice lacking LT or LT receptors, which are devoid of FDC, develop generalized lymphocytic infiltrates, which are suggestive of autoimmunity. These findings suggest that FDC possibly protect organism against autoimmunity by the removal of potentially self-reactive debris from germinal centres.[13]

Interaction with B-cellsEdit

Noncognate (not antigen specific) B cells play a significant role in the transport of antigens to FDCs. They capture immune complexes in CR1/2-dependent way either directly from the lymph or from macrophages, and move to the lymphoid tissue, where they transfer complement opsonized antigen to the FDCs.[15][16]

FDCs, in turn, attract B cells with chemoattractant CXCL13. B cells lacking CXCR5, the receptor for CXCL13, still enter the white pulp, but are mislocalized and disorganized. To generate follicular structures, FDCs need to be stimulated by lymphotoxin (LT), a mediator produced by B cells. The stimulation of CXCR5 on B cells upregulates LT production, which leads to FDCs activation and stimulates further CXCL13 secretion, thus generating a positive feed-forward loop. This results in the formation of GC, where antigen-activated B cells are trapped to undergo somatic mutation, positive and negative selection, isotype switching, and differentiation into high-affinity plasma cells and memory B cells. Adhesion between FDCs and B cells is mediated by ICAM-1 (CD54)–LFA-1 (CD11a) and VCAM–VLA-4 molecules.[7] Activated B-cells with low affinity to antigen captured on FDCs surface as well as autoreactive B-cells undergo apoptosis, whereas B cells bound to FDCs through the antigen complex, survive due to apoptosis blockage caused by interaction with FDCs.


Rare primary FDC-tumors have been described. These sarcomas often involve lymphoid tissues, but in a number of cases the tumor has been found in the liver, bile duct, pancreas, thyroid, nasopharynx, palatum, submucosa of the stomach or the duodenum. In a number of chronic inflammatory conditions, cells producing CXCL13 chemokine and carrying such FDCs markers as VCAM-1 and CD21, have been observed at quite unexpected sites, including synovial tissue of patients with rheumatoid arthritis (RA), salivary glands of patients with Sjögren’s syndrome, and the skin of patients with pseudo B cells lymphoma.[7] Follicular dendritic cells participate in HIV-1 infection development both, by providing a haven for HIV-1[17][18][19] and by stimulating HIV-1 replication in adjacent infected monocytic cells via a juxtacrine signaling mechanism.[20] There are also some evidences, that FDCs may promote prion replication and neuroinvasion in neuroinvasive scrapie.[21]

See alsoEdit


  1. ^ Liu Y, Grouard G, de Bouteiller O, Banchereau J (1996). Follicular dendritic cells and germinal centers. Int Rev Cytol. International Review of Cytology. 166. pp. 139–79. doi:10.1016/S0074-7696(08)62508-5. ISBN 978-0-12-364570-8. PMID 8881775.
  2. ^ Heesters, Balthasar A.; Myers, Riley C.; Carroll, Michael C. (2014-06-20). "Follicular dendritic cells: dynamic antigen libraries". Nature Reviews Immunology. 14 (7): 495–504. doi:10.1038/nri3689. ISSN 1474-1733. PMID 24948364. S2CID 7082877.
  3. ^ Aguzzi, Adriano; Kranich, Jan; Krautler, Nike Julia (March 2014). "Follicular dendritic cells: origin, phenotype, and function in health and disease". Trends in Immunology. 35 (3): 105–113. doi:10.1016/ ISSN 1471-4906. PMID 24315719.
  4. ^ Banchereau J, Steinman RM (1998). "Dendritic cells and the control of immunity". Nature. 392 (6673): 245–52. doi:10.1038/32588. PMID 9521319. S2CID 4388748.van Nierop K, de Groot C (2002). "Human follicular dendritic cells: function, origin and development". Semin Immunol. 14 (4): 251–7. doi:10.1016/S1044-5323(02)00057-X. PMID 12163300.
  5. ^ a b Male D, Brostoff J, Roth D, Roitt I (2007). Immunology (7th ed.). ISBN 978-0-323-03399-2.
  6. ^ Banchereau J, Steinman RM (1998). "Dendritic cells and the control of immunity". Nature. 392 (6673): 245–52. doi:10.1038/32588. PMID 9521319. S2CID 4388748.
  7. ^ a b c d van Nierop K, de Groot C (2002). "Human follicular dendritic cells: function, origin and development". Semin Immunol. 14 (4): 251–7. doi:10.1016/S1044-5323(02)00057-X. PMID 12163300.
  8. ^ Kapasi ZF, Qin D, Kerr WG, Kosco-Vilbois MH, Shultz LD, Tew JG, Szakal AK (1998). "Follicular dendritic cell (FDC) precursors in primary lymphoid tissues". The Journal of Immunology. 160 (3): 1078–84. PMID 9570519.
  9. ^ Wang Y, Wang J, Sun Y, Wu Q, Fu YX (2001). "Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells". Journal of Immunology. 166 (1): 330–7. doi:10.4049/jimmunol.166.1.330. PMID 11123309.
  10. ^ Ettinger R, Mebius R, Browning JL, Michie SA, van Tuijl S, Kraal G, van Ewijk W, McDevitt HO (1998). "Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development". Int Immunol. 10 (6): 727–41. doi:10.1093/intimm/10.6.727. PMID 9678753.
  11. ^ Cyster JG (2010). "B cell follicles and antigen encounters of the third kind". Nat Immunol. 11 (11): 989–96. doi:10.1038/ni.1946. PMID 20959804. S2CID 26439962.
  12. ^ Balthasar, Heesters; Priyadarshini, Chatterjee; Young-A, Kim; Santiago, Gonzalez; Michael, Kuligowski; Tomas, Kirchhausen; Michael, Carroll (2013). "Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell binding and activation". Frontiers in Immunology. 4. doi:10.3389/conf.fimmu.2013.02.00438. ISSN 1664-3224.
  13. ^ a b Aguzzi A, Krautler NJ (2010). "Characterizing follicular dendritic cells: A progress report". European Journal of Immunology. 40 (8): 2134–8. doi:10.1002/eji.201040765. PMID 20853499.
  14. ^ Kranich J, Krautler NJ, Heinen E, Polymenidou M, Bridel C, Schildknecht A, Huber C, Kosco-Vilbois MH, Zinkernagel R, Miele G, Aguzzi A (2008). "Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8". J Exp Med. 205 (6): 1293–302. doi:10.1084/jem.20071019. PMC 2413028. PMID 18490487.
  15. ^ Phan, Tri Giang; Grigorova, Irina; Okada, Takaharu; Cyster, Jason G (2007-07-29). "Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells". Nature Immunology. 8 (9): 992–1000. doi:10.1038/ni1494. ISSN 1529-2908. PMID 17660822. S2CID 35256900.
  16. ^ Carrasco, Yolanda R.; Batista, Facundo D. (July 2007). "B Cells Acquire Particulate Antigen in a Macrophage-Rich Area at the Boundary between the Follicle and the Subcapsular Sinus of the Lymph Node". Immunity. 27 (1): 160–171. doi:10.1016/j.immuni.2007.06.007. ISSN 1074-7613. PMID 17658276.
  17. ^ Cavert W, Notermans DW, Staskus K, Wietgrefe SW, Zupancic M, Gebhard K, Henry K, Zhang ZQ, Mills R, McDade H, Schuwirth CM, Goudsmit J, Danner SA, Haase AT (1997). "Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection". Science. 276 (5314): 960–4. doi:10.1126/science.276.5314.960. PMID 9139661.
  18. ^ Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS (1993). "HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease". Nature. 362 (6418): 355–8. doi:10.1038/362355a0. PMID 8455722. S2CID 4326634.
  19. ^ Heesters, Balthasar A.; Lindqvist, Madelene; Vagefi, Parsia A.; Scully, Eileen P.; Schildberg, Frank A.; Altfeld, Marcus; Walker, Bruce D.; Kaufmann, Daniel E.; Carroll, Michael C. (2015-12-01). "Follicular Dendritic Cells Retain Infectious HIV in Cycling Endosomes". PLOS Pathogens. 11 (12): e1005285. doi:10.1371/journal.ppat.1005285. ISSN 1553-7374. PMC 4666623. PMID 26623655.
  20. ^ Ohba K, Ryo A, Dewan MZ, Nishi M, Naito T, Qi X, Inagaki Y, Nagashima Y, Tanaka Y, Okamoto T, Terashima K, Yamamoto N (2009). "Follicular dendritic cells activate HIV-1 replication in monocytes/macrophages through a juxtacrine mechanism mediated by P-selectin glycoprotein ligand 1". Journal of Immunology. 183 (1): 524–32. doi:10.4049/jimmunol.0900371. PMID 19542463.
  21. ^ Montrasio F, Frigg R, Glatzel M, Klein MA, Mackay F, Aguzzi A, Weissmann C (2000). "Impaired prion replication in spleens of mice lacking functional follicular dendritic cells". Science. 288 (5469): 1257–9. doi:10.1126/science.288.5469.1257. PMID 10818004.